[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367979-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367979-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","expression-profile-and-clinical-relevance-of-adar-family-genes-in-head-and-neck-squamous-cell-carcinoma","Expression Profile and Clinical Relevance of ADAR Family Genes in Head and Neck Squamous Cell Carcinoma","","ADAR1 (ADAR), ADAR2 (ADARB1), and ADAR3 (ADARB2) are adenosine RNA deaminase enzymes involved in RNA metabolism, but their roles in head and neck squamous cell carcinoma (HNSCC) remain unclear. This study uses quantitative PCR on matched tumor and normal tissues, FFPE tumors, and HNSCC cell lines, complemented by transcriptomic and clinical analyses from TCGA. ADARB2 is significantly downregulated in tumors and discriminates malignant from non-malignant tissues, while high ADARB2 expression predicts improved survival. Low ADARB2 aligns with oncogenic pathway enrichment including Wnt/β-catenin, MYC targets, and TGF-β1.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/expression-profile-and-clinical-relevance-of-adar-family-genes-in-head-and-neck-squamous-cell-carcinoma/367979/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/expression-profile-and-clinical-relevance-of-adar-family-genes-in-head-and-neck-squamous-cell-carcinoma/367979.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What enzymes are included in the ADAR family studied in HNSCC?","Question",{"text":63,"@type":64},"The study focuses on ADAR1 (ADAR), ADAR2 (ADARB1), and ADAR3 (ADARB2), which are adenosine RNA-specific deaminase enzymes involved in RNA metabolism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which ADAR gene shows the strongest change in HNSCC tumor tissues?",{"text":68,"@type":64},"ADARB2 is significantly downregulated in HNSCC tumor tissues compared with adjacent normal mucosa and shows discriminatory capability between malignant and non-malignant tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"How is ADARB2 expression related to patient prognosis?",{"text":72,"@type":64},"Higher ADARB2 expression is associated with significantly improved overall survival, while lower ADARB2 expression correlates with enrichment of oncogenic pathways and poorer clinical prognosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367979,1790203938,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nExpression Profile and Clinical Relevance of ADAR Family Genes in Head and Neck Squamous Cell Carcinoma  \nTomasz Kolenda 1,2, *,†, Piotr Białas 3, *,†, Paulina Poter 4,5, Marlena Janiczek-Polewska 6,7, Anna Zapłata 8, Kacper Guglas 4, Patrycja Mantaj 9, Anna Przybyła 4,10,11, Urszula Kazimierczak 10,11, Ewa Leporowska 8, Zefiryn Cybulski 1,2 and Anna Teresiak 1,4  \nAcademic Editor: Christos Yapijakis  \nReceived: 4 September 2025  \nRevised: 30 September 2025  \nAccepted: 17 October 2025  \nPublished: 2 November 2025  \nCitation: Kolenda, T.; Białas, P.; Poter, P.; Janiczek-Polewska, M.; Zapłata, A.; Guglas, K.; Mantaj, P.; Przybyła, A.; Kazimierczak, U.; Leporowska, E.; et al. Expression Profile and Clinical Relevance of ADAR Family Genes in Head and NeckSquamous Cell Carcinoma. Genes 2025, 16, 1316 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16111316  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Research and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland;  \nzefiryn.cybulski@wco.pl (Z.C.); anna.teresiak@wco.pl (A.T.)  \n2 Microbiology Laboratory, Greater Poland Cancer Centre, Garbary Street 15, 61-866 Poznan, Poland  \n3 Department of Cell Biology, Poznan University of Medical Sciences, Rokietnicka 5D, 60-806 Poznan, Poland  \n4 Laboratory of Cancer Genetics, Greater Poland Cancer Centre, 15 Garbary Street, 61-866 Poznan, Poland; [paulina.poter@wco.pl](paulina.poter@wco.pl) (P.P.); [kacper.guglas@wco.pl](kacper.guglas@wco.pl) (K.G.); [annaprzybyla@ump.edu.pl](annaprzybyla@ump.edu.pl) (A.P.)  \n5 Department of Oncologic Pathology and Prophylaxis, Greater Poland Cancer Centre, Poznan University of Medical Sciences, 15 Garbary, 61-866 Poznan, Poland  \n6 Department of Clinical Oncology, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland; [marlena.janiczek@wco.pl](marlena.janiczek@wco.pl)  \n7 Department of Electroradiology, Poznan University of Medical Sciences, Garbary 15, 61-866 Poznan, Poland  \n8 Department of Laboratory Diagnostics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland; anna.zaplata@wco.pl (A.Z.); [ewa.leporowska@wco.pl](ewa.leporowska@wco.pl) (E.L.)  \n9 Radiation Protection Department, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland; [patrycja.mantaj@wco.pl](patrycja.mantaj@wco.pl)  \n10 Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland; [ukazimierczak@ump.edu.pl](ukazimierczak@ump.edu.pl)  \n11 Department of Cancer Immunology, Poznan University of Medical Sciences, Rokietnicka 8, 60-806 Poznan, Poland  \n* Correspondence: [tomasz.kolenda@wco.pl](tomasz.kolenda@wco.pl) (T.K.); [pbialas@ump.edu.pl](pbialas@ump.edu.pl) (P.B.)† These authors contributed equally to this work.  \nAbstract  \nBackground: ADAR1 (ADAR), ADAR2 (ADARB1), and ADAR3 (ADARB2) are deaminase adenosine RNA-specific enzymes that play a significant role in RNA metabolism. ADAR1 (ADAR) and ADAR2 (ADARB1) catalyze A-to-I editing and ADAR3 (ADARB2) plays a regulatory role. The role of these three genes still remains unknown in head and neck cancers (HNSCC) . The aim of this study is to reveal the role of deaminase adenosine RNA-specific enzymes in pathomechanisms of HNSCC and to investigate their potential utility as diagnostic and/or prognostic biomarkers. Methods: The quantitative PCR analysis was conducted using RNA isolated from 22 pairs of matched tumor and adjacent normal tissues, 76 formalin-fixed paraffin-embedded (FFPE) tumor samples, and a panel of HNSCC cell lines (DOK, SCC-25, SCC-40, FaDu, and CAL-27) . In parallel, transcriptomic and clinical data from the Cancer G","cbCaivDv8eK8CPWs","https://ap.wps.com/l/cbCaivDv8eK8CPWs","pdf",4794198,27,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# 1. Introduction","[{\"question\":\"What enzymes are included in the ADAR family studied in HNSCC?\",\"answer\":\"The study focuses on ADAR1 (ADAR), ADAR2 (ADARB1), and ADAR3 (ADARB2), which are adenosine RNA-specific deaminase enzymes involved in RNA metabolism.\"},{\"question\":\"Which ADAR gene shows the strongest change in HNSCC tumor tissues?\",\"answer\":\"ADARB2 is significantly downregulated in HNSCC tumor tissues compared with adjacent normal mucosa and shows discriminatory capability between malignant and non-malignant tissues.\"},{\"question\":\"How is ADARB2 expression related to patient prognosis?\",\"answer\":\"Higher ADARB2 expression is associated with significantly improved overall survival, while lower ADARB2 expression correlates with enrichment of oncogenic pathways and poorer clinical prognosis.\"}]","Expression Profile and Clinical Relevance of ADAR Family Genes in Head and Neck Squamous Cell Carcinoma | PDF",1790174096,68,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4da0b78ffe13abd3ac124a61117900ac.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/907e09ff94c1a2cbfde58d46ef673879.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0563a48b0e22825e3a17b899d0ed3658.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdf38cada3b5df2d766f564afdd7adde.webp",980,1385]